VANGUARD GROUP INC 13D and 13G filings for Achieve Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-30 10:59 am Sale | 2025-03-31 | 13G | Achieve Life Sciences, Inc. ACHV | VANGUARD GROUP INC | 1,717,014 4.950% | -223,374 (-11.51%) | Filing |
| 2024-11-12 12:14 pm Unchanged | 2024-09-30 | 13G | Achieve Life Sciences, Inc. ACHV | VANGUARD GROUP INC | 1,940,388 5.650% | 0 (Unchanged) | Filing |
| 2024-11-04 10:59 am Purchase | 2024-09-30 | 13G | Achieve Life Sciences, Inc. ACHV | VANGUARD GROUP INC | 1,940,388 5.650% | 1,940,388 (New Position) | Filing |